Cleveland Clinic strikes research deal for ‘good cholesterol’ drug

The Cleveland Clinic will work with Esperion Therapeutics Inc. to develop “good cholesterol” therapies to fight cardiovascular disease. Privately held biopharmaceutical company Esperion in Plymouth, Mich. — which discovers, develops and commercializes therapies for cardiovascular diseases — announced its “collaborative research agreement” with the Clinic — the nation’s leading heart medical center — on Monday. […]